Showing results (141-150 of 618) with videos related to
Sort By:
Pageof 62
Magnetic Resonance in Medicine|August 1, 2014
Short-T2 imaging for quantifying concentration of sodium (23 Na) of bi-exponential T2 relaxationYongxian Qian, Ashok Panigrahy, Charles M Laymon, et al.Neurosurgery|April 3, 2025
Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant RecurrenceNeslihan Nisa Gecici, Ahmed Habib, Arka N Mallela, et al.Journal of Neurosurgery|March 5, 2013
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical articleMarlon G Saria, Courtney Corle, Jethro Hu, et al.Current Neurology and Neuroscience Reports|May 4, 2005
Targeted molecular therapy of malignant gliomasSantosh Kesari, Naren Ramakrishna, Claire Sauvageot, et al.Journal of Neuro-Oncology|April 27, 2022
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patientsVasileios K Kavouridis, Keith L Ligon, Patrick Y Wen, et al.Current Opinion in Neurology|April 4, 2017
Immunomodulation for glioblastomaDavid A Reardon, Patrick Y Wen, Kai W Wucherpfennig, et al.Current Treatment Options in Neurology|March 10, 2015
How treatment monitoring is influencing treatment decisions in glioblastomasMartha R Neagu, Raymond Y Huang, David A Reardon, et al.Discovery Medicine|July 16, 2015
One size should not fit all: advancing toward personalized glioblastoma therapyDavid A Reardon, Keith L Ligon, E Antonio Chiocca, et al.Current Neurology and Neuroscience Reports|May 24, 2020
Novel Therapies for GlioblastomaElisa K Liu, Erik P Sulman, Patrick Y Wen, et al.Expert Review of Neurotherapeutics|April 3, 2013
Current and future directions for Phase II trials in high-grade gliomaBrian M Alexander, Eudocia Q Lee, David A Reardon, et al.Pageof 62